Minimal residual disease in acute lymphoblastic leukemia: technical aspects and implications for clinical interpretation
Author:
Affiliation:
1. Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea
2. Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea
Publisher
The Korean Society of Hematology
Subject
Hematology
Link
https://pdf.medrang.co.kr/BR/2020/055/BR2055-00-04.pdf
Reference66 articles.
1. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
2. Acute Lymphoblastic Leukemia: Monitoring Minimal Residual Disease as a Therapeutic Principle
3. Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia
4. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
5. MRD Detection in Acute Lymphoblastic Leukemia Patients Using Ig/TCR Gene Rearrangements as Targets for Real-Time Quantitative PCR
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Massively parallel identification of single-cell immunophenotypes;2024-04-04
2. Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy;Frontiers in Oncology;2024-04-03
3. Minimal Residual Disease in Acute Lymphoblastic Leukemia;Cancer Consult;2023-11-18
4. Minimal residual disease detection by next-generation sequencing of different immunoglobulin gene rearrangements in pediatric B-ALL;Nature Communications;2023-11-17
5. miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease;Leukemia;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3